Storia della carriera di George G Nomikos
Precedenti posizioni note di George G Nomikos
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| LIPOCINE INC. | Direttore Tecnico/Scientifico/R&S | 03/11/2022 | 01/04/2023 |
| SCHOLAR ROCK HOLDING CORPORATION | Direttore Tecnico/Scientifico/R&S | 05/09/2019 | 02/11/2022 |
| AMGEN INC. | Corporate Officer/Principal | 01/10/2007 | 01/10/2007 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01/01/2006 | 01/01/2006 |
| Karolinska Institutet | Corporate Officer/Principal | - | - |
| CYNAPSUS THERAPEUTICS INC | Direttore Tecnico/Scientifico/R&S | 30/10/2007 | - |
Formazione di George G Nomikos
| National & Kapodistrian University of Athens | Doctorate Degree |
| University of British Columbia | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 5 |
| Canada | 3 |
| Grecia | 2 |
Posizioni
| Chief Tech/Sci/R&D Officer | 3 |
| Corporate Officer/Principal | 3 |
| Doctorate Degree | 2 |
Settori
| Health Technology | 6 |
| Consumer Services | 4 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 4 |
|---|---|
| SCHOLAR ROCK HOLDING CORPORATION | Health Technology |
| AMGEN INC. | Health Technology |
| ELI LILLY AND COMPANY | Health Technology |
| LIPOCINE INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Cynapsus Therapeutics, Inc.
 Cynapsus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cynapsus Therapeutics, Inc. operated as a pharmaceutical company, which developed an improved dosing formulation of an approved drug used to treat the symptoms of Parkinson's disease. The company was founded by Andrew Williams and David Hill on January 16, 2004 and was headquartered in Toronto, Canada. | Health Technology |
- Borsa valori
- Insiders
- George G Nomikos
- Esperienza
